Impact of Hyperarch Fascia Training on Ankle Health and Exercise Performance

Exclusion Criteria

• •History of Achilles tendon rupture or surgery within the last 12 months. Use of prescribed corticosteroids or other tendon-specific treatments within four weeks prior to the study.
• •Current enrollment in any structured fascial or tendon rehabilitation programs.
• •Pregnancy, breastfeeding, or plans to become pregnant during the study period.
• •Any medical conditions that may interfere with running or exercise performance or study participation.
• •Not willing to sign an NDA regarding the fascia training techniques used in this study
• •Use of medical interventions, such as growth hormone or peptides, that may influence tissue adaptation to exercise.
• •Current supplementation with common soft-tissue ingredients, such as glucosamine, chondroitin, methylsufonylmethane (MSM), or collagen protein.
• •Presents with Ehlers-Danlos syndrome (EDS) or hypermobility History or current drug abuse
• •History or current cigarette smoke (including vaping) within the past 14 days from the screening visit
• •Insulin-dependent diabetes and/or metformin use
• •Chronic kidney or liver disease
• •Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such conditions might be aggravated as a result of treatment
• •Clinically diagnosed as depressed or taking depression or anti anxiety medication
• •History of uncontrolled cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other)
• •Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurements
• •Currently has been diagnosed with cancer or has been in remission for less than 1 year
• •Participation in any other investigational study within 30 days prior to consent.